Annual report pursuant to Section 13 and 15(d)

CORPORATE REORGANIZATION AND EXERCISE OF CALL OPTIONS OF CURECELL AND ATVIO (Tables)

v3.10.0.1
CORPORATE REORGANIZATION AND EXERCISE OF CALL OPTIONS OF CURECELL AND ATVIO (Tables)
12 Months Ended
Nov. 30, 2018
Business Combination, Segment Allocation [Table Text Block]
Total assets acquired:      
           Cash and cash equivalents $ 58  
           Property and equipment, net   1,104  
           Inventory   148  
           Other assets   300  
           Other Intangible assets (a)   3,933  
           Goodwill (b)   3,950  
           Total assets   9,493  
       
Total liabilities assumed:      
           Deferred income from the Company and others   1,945  
           Deferred taxes   80  
           Fair value of convertible loan from the Company   892  
           Non-controlling interests   299  
           Other liabilities   1,487  
Total liabilities   4,703  
Total consideration transferred $ 4,790  
       
Fair value of 36.4% of shared issued   1,853  
Acquisition date fair value of previously held equity interest   2,937  
Total consideration transferred $ 4,790  
Business Acquisition, Pro Forma Information [Table Text Block]
    Year Ended November 30,  
    2018     2017  
    (in thousands)  
Revenue $ 18,794   $ 10,216  
Net loss $ 20,919   $ 14,520